aminoimidazole carboxamide has been researched along with Pulmonary Disease, Chronic Obstructive in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hu, XG; Liu, B; Ma, LJ; Qi, Y; Shang, JY; Sun, BB; Zhang, GJ | 1 |
Cheng, XY; Huang, C; Li, J; Li, YY; Yao, HW | 1 |
2 other study(ies) available for aminoimidazole carboxamide and Pulmonary Disease, Chronic Obstructive
Article | Year |
---|---|
Inhibition of AMPK expression in skeletal muscle by systemic inflammation in COPD rats.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Disease Models, Animal; Down-Regulation; Gene Expression Regulation, Enzymologic; Male; Muscle Weakness; Muscle, Skeletal; Pulmonary Disease, Chronic Obstructive; Rats, Wistar; Resveratrol; Ribonucleotides; RNA, Messenger; Sirtuin 1; Stilbenes; Time Factors; Tumor Necrosis Factor-alpha | 2014 |
AMP-activated protein kinase reduces inflammatory responses and cellular senescence in pulmonary emphysema.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Cell Line; Cellular Senescence; Energy Metabolism; Female; Humans; Inflammation; Lipid Metabolism; Lung; Male; Mice; Mice, Inbred C57BL; Pancreatic Elastase; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Pyrazoles; Pyrimidines; Respiratory Mucosa; Ribonucleotides; Smoking | 2017 |